A detailed history of Wallace Advisory Group, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Wallace Advisory Group, LLC holds 957 shares of WST stock, worth $304,249. This represents 0.25% of its overall portfolio holdings.

Number of Shares
957
Previous 916 4.48%
Holding current value
$304,249
Previous $344 Million 1.95%
% of portfolio
0.25%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$338.27 - $413.0 $13,869 - $16,933
41 Added 4.48%
957 $337 Million
Q4 2023

Jan 08, 2024

SELL
$318.29 - $392.21 $37,239 - $45,888
-117 Reduced 11.33%
916 $344 Million
Q3 2023

Oct 05, 2023

SELL
$354.9 - $412.41 $3,549 - $4,124
-10 Reduced 0.96%
1,033 $395 Million
Q1 2023

May 10, 2023

BUY
$232.5 - $346.47 $1,627 - $2,425
7 Added 0.68%
1,043 $361 Million
Q4 2022

Feb 21, 2023

BUY
$209.34 - $261.61 $216,876 - $271,027
1,036 New
1,036 $244 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.5B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Wallace Advisory Group, LLC Portfolio

Follow Wallace Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wallace Advisory Group, LLC with notifications on news.